FIGURE 3.
Effects of reslizumab on asthma control questionnaire-7 (ACQ-7) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. (a) Changes from baseline ACQ-7 score at week 16 and week 52 and (b) changes relative to placebo throughout the study. Increase in control is represented by a decrease in ACQ-7 score [16, 19]. LS: least square.